
Celon Pharma S.A.
WSE:CLN.WA
15.96 (PLN) • At close December 14, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Celon Pharma S.A. |
Symbool | CLN.WA |
Munteenheid | PLN |
Prijs | 15.96 |
Beurswaarde | 814,861,740 |
Dividendpercentage | 0.53% |
52-weken bereik | 13.1 - 18.4 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Maciej Wieczorek Ph.D. |
Website | https://www.celonpharma.com |
An error occurred while fetching data.
Over Celon Pharma S.A.
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (PLN)
Cijfers zijn in miljoenen (PLN)